Cargando…
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Background: The ChAdOx1 nCoV-19 vaccine has been widely administered against SARS-CoV-2 infection; however, data regarding its immunogenicity, reactogenicity, and potential differences in responses among Asian populations remain scarce. Methods: 270 participants without prior COVID-19 were enrolled...
Autores principales: | Chang, Jer-Hwa, Chiou, Jeng-Fong, Hung, Ching-Sheng, Liu, Ming-Che, Chang, Hui-Wen, Hong, Shiao-Ya, Wang, Cheng-Yi, Lin, Yi-Ling, Hsieh, Yi-Chen, Chung, Chi-Li, Su, Ying-Shih, Hsiao, Shu-Tai Shen, Liu, Doresses, Liang, Jian-Jong, Liao, Chun-Che, Chang, Chih-Shin, Lai, Kevin Shu-Leung, Chuang, Han-Chuan, Chien, Ko-Ling, Wu, Wei-Ciao, Lee, Yuan-Chii G., Lin, Sey-En, Shen, Yung-Kang, Hsu, Chiung-Fang, Wang, Jude Chu-Chun, Hsiao, Shih-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874464/ https://www.ncbi.nlm.nih.gov/pubmed/35214770 http://dx.doi.org/10.3390/vaccines10020312 |
Ejemplares similares
-
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis
por: Hsiao, Shih-Hsin, et al.
Publicado: (2023) -
The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection
por: Cheng, Chung-Yi, et al.
Publicado: (2022) -
Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
por: Lin, Ting-Yun, et al.
Publicado: (2022) -
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021) -
SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
por: Cheng, Chung-Yi, et al.
Publicado: (2022)